New study of hydroxychloroquine usage may help personalize lupus treatment
RI-MUHC researchers identify factors associated with poor outcomes for lupus patients
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
Canada approves HIV self-testing kit ahead of World AIDS Day 2020
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Marina Klein and Bernard Robaire!
Spike in peanut and nut anaphylaxis in children at Halloween and Easter
New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year
$2M funding to mitigate COVID-19 impact on tuberculosis services
Dr. Madhukar Pai launches studies in India, Indonesia, Nigeria and Peru
Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill
Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery
From silent infection to rapid death: Why are some people more vulnerable to COVID-19?
Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases
New study of therapy options in metastatic melanoma
RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors
Lashanda Skerritt awarded Vanier Canada Graduate Scholarship
“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC...
Inappropriate prescriptions sending hospitalized seniors back to the ER
Improving hospital prescribing practices may reduce risk of rehospitalization and death
Early treatment trial of hydroxychloroquine shows no symptomatic benefit for COVID-19 patients
Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine
A good showing for the IDIGH Program in 2020-2021 FRQS awards
Congratulations to researchers and trainees!
Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
COVID-19 pandemic: Looking back to better tackle future challenges
In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies
Innovation Moves Online for the 2020 McGill Clinical Innovation Competition
RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize